LifeVantage Announces Additional Share Repurchase Program

LifeVantage Announces Additional Share Repurchase Program

   Company's Board Authorizes Repurchase of an Additional $5 Million of Its
                                 Common Stock

     Board of Directors is Exploring Options to Reduce Outstanding Shares

SALT LAKE CITY, March 22, 2013 (GLOBE NEWSWIRE) -- LifeVantage Corporation
(Nasdaq:LFVN), a company dedicated to helping people achieve healthy living
through a combination of a compelling business opportunity and scientifically
validated products, including its patented dietary supplement Protandim^®, the
Nrf2 Synergizer^®, announced today that its Board of Directors approved a
share repurchase program that authorizes the Company to utilize up to $5
million to purchase additional shares of its common stock. The Company is
nearing completion of repurchasing the $5 million under the repurchase program
that was previously approved and announced in December 2012. 

The newly approved repurchase authorization permits LifeVantage to purchase
shares from time to time through a variety of methods, including in the open
market, through privately negotiated transactions or other means as determined
by the company's management, in accordance with applicable securities laws. As
part of the repurchase program, the Company expects that it will enter into a
pre-arranged stock repurchase plan which would operate in accordance with
guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934.
Transactions, if any, under the pre-arranged repurchase plan would be effected
in accordance with the terms of the stock repurchase plan, including specified
price, volume and timing conditions.

In addition, the Company has begun the process of analyzing the merits of
potential methods of reducing the number of outstanding shares.The Company is
in the process of engaging an investment bank to assist with the analysis.The
Company will provide additional details about the results of its analysis as

"We are pleased to announce an additional stock buyback program.With our
strong balance sheet and healthy cash position, we believe we will be able to
implement the program at the appropriate time while maintaining sufficient
capital to continue our efforts to take advantage of future growth
opportunities," Douglas C. Robinson, LifeVantage President and CEO, stated.
"We also are exploring more broadly options to reduce the number of
outstanding shares, which we believe would further demonstrate our commitment
to enhancing long-term shareholder value.We are currently in the initial
phase of evaluating these options and look forward to providing updates once
we have obtained findings from the analysis."

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq:LFVN), a leader in Nrf2 science and the maker
of Protandim®, the Nrf2 Synergizer® patented dietary supplement, is a science
based nutraceutical company. LifeVantage is dedicated to visionary science
that looks to transform wellness and anti-aging internally and externally with
products that dramatically reduce oxidative stress at the cellular level. The
Company was founded in 2003 and is headquartered in Salt Lake City, UT.

The LifeVantage Corporation logo is available at

Forward-Looking Statements

This document contains forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.
Words and expressions reflecting optimism, satisfaction or disappointment with
current prospects, as well as words such as "believe," "hopes," "intends,"
"estimates," "expects," "projects," "plans," "anticipates," "look forward to"
and variations thereof, identify forward-looking statements, but their absence
does not mean that a statement is not forward-looking. Examples of
forward-looking statements include, but are not limited to, statements we make
regarding our expectation that we will repurchase shares, efforts to reduce
the number of outstanding shares, and our future prospects and growth.Such
forward-looking statements are not guarantees of performance and the Company's
actual results could differ materially from those contained in such
statements. These forward-looking statements are based on the Company's
current expectations and beliefs concerning future events affecting the
Company and involve known and unknown risks and uncertainties that may cause
the Company's actual results or outcomes to be materially different from those
anticipated and discussed herein. These risks and uncertainties include, among
others, the Company's inability to successfully expand our operations in
existing and other markets and thereafter manage our growth; the Company's
ability to strengthen its business in Japan; the Company's reliance on third
party suppliers and manufacturers; the Company's ability to retain independent
distributors or to attract new independent distributors on an ongoing basis;
the Company's ability to expand its product offerings; violations of law or
our procedures by the Company's independent distributors; the potential for
third-party and governmental actions involving the Company's network marketing
efforts; the potential for product liability claims against the Company; the
risk that government regulators and regulations could adversely affect the
Company's business; future laws or regulations may hinder or prohibit the
production or sale of the Company's existing product and any future products;
unfavorable publicity could materially hurt the Company's business; the
Company's ability to access raw materials for its Products as it grows; risks
associated with foreign currency fluctuations; and the Company's ability to
protect its intellectual property rights and the value of its product. These
and other risk factors are discussed in greater detail in the Company's Annual
Report on Form 10-K and its Quarterly Report on Form 10-Q under the caption
"Risk Factors," and in other documents filed by the Company from time to time
with the Securities and Exchange Commission. The Company cautions investors
not to place undue reliance on the forward-looking statements contained in
this document. All forward-looking statements are based on information
currently available to the Company on the date hereof, and the Company
undertakes no obligation to revise or update these forward-looking statements
to reflect events or circumstances after the date of this document, except as
required by law.

CONTACT: Investor Relations Contact:
         Cindy England (801) 432-9036
         Director of Investor Relations
         John Mills (310) 954-1105
         Senior Managing Director, ICR, LLC

company logo
Press spacebar to pause and continue. Press esc to stop.